An Adjustable Dalteparin Sodium Dose Regimen for the Prevention of Clotting in the Extracorporeal Circuit in Hemodialysis: A Clinical Trial of Safety and Efficacy (the PARROT Study)-Reference-Cited by-同舟云学术

An Adjustable Dalteparin Sodium Dose Regimen for the Prevention of Clotting in the Extracorporeal Circuit in Hemodialysis: A Clinical Trial of Safety and Efficacy (the PARROT Study)

Published:2018-01 Issue: Volume:5 Page:205435811880910
ISSN:2054-3581
Container-title:Canadian Journal of Kidney Health and Disease
language:en
Short-container-title:Can J Kidney Health Dis

Author:

Soroka Steven¹,Agharazii Mohsen²,Donnelly Sandra³,Roy Louise⁴,Muirhead Norman⁵,Cournoyer Serge⁶,MacKinnon Martin⁷,Pannu Neesh⁸,Barrett Brendan⁹,Madore François¹⁰,Tennankore Karthik¹,Wilson Jo-Anne¹,Hilton Fiona¹¹¹²,Sherman Nancy¹²,Wolter Kevin¹²,Orazem John¹²,Feugère Guillaume¹³

Affiliation:

1. Division of Nephrology, Dalhousie University, Halifax, NS, Canada

2. Endocrinology and Nephrology, CHU de Québec Research Center, L’Hôtel-Dieu de Québec, Université Laval, Québec City, QC, Canada

3. Division of Nephrology, William Osler Health System, Brampton Civic Hospital, Brampton, ON, Canada

4. Department of Medicine, Centre Hospitalier de l’Université de Montréal, Montréal, QC, Canada

5. Department of Medicine, London Health Sciences Centre, Western University, London, ON, Canada

6. Nephrology, Hôpital Charles-LeMoyne, Greenfield Park, QC, Canada

7. Division of Nephrology, Horizon Health, Saint John, NB, Canada

8. Nephrology, University of Alberta, Edmonton, AB, Canada

9. Division of Nephrology, Memorial University of Newfoundland, St. John’s, Newfoundland and Labrador, Canada

10. Faculté de Médecine, Hôpital du Sacré-Cœur de Montréal, Montréal, QC, Canada

11. Pfizer Essential Health, Pfizer Inc, Groton, CT, USA

12. Pfizer Essential Health, Pfizer Inc, New York, NY, USA

13. Pfizer Essential Health, Pfizer Canada Inc, Kirkland, QC, Canada

Funder

Pfizer

Publisher

SAGE Publications

Subject

Nephrology

Link

http://journals.sagepub.com/doi/pdf/10.1177/2054358118809104

Reference15 articles.

1. Review article: Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments

2. V.1 Haemodialysis and prevention of system clotting

3. Safety and Efficacy of Low Molecular Weight Heparins for Hemodialysis in Patients with End-Stage Renal Failure: A Meta-analysis of Randomized Trials

4. Efficacy and safety of low molecular weight heparin compared to unfractionated heparin for chronic outpatient hemodialysis in end stage renal disease: systematic review and meta-analysis

5. Parenteral Anticoagulants

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Do regional citrate anticoagulants versus low molecular weight heparins and 0.9% sodium chloride reduce extracorporeal circuit clotting in adult renal replacement therapy patients? A literature review;Renal Society of Australasia Journal;2023-11

2. The Australian and New Zealand dialysis workforce study 2021;Renal Society of Australasia Journal;2023-11

3. Hepatitis B vaccination in patients with stage 4/5 chronic kidney disease – a scoping review;Renal Society of Australasia Journal;2023-11

4. Expanded hemodialysis: Is anticoagulation of the dialysis circuit different from online hemodiafiltration and high‐flux hemodialysis?;Therapeutic Apheresis and Dialysis;2021-04-29

5. Efficacy of enoxaparin in preventing coagulation during high-flux haemodialysis, expanded haemodialysis and haemodiafiltration;Clinical Kidney Journal;2020-06-22